Dr. Emlyn Clay

Back in 2009, Dr Emlyn Clay was working as a researcher for a biotech company, Verona Pharma plc, that was doing routine cardiotoxicology studies and became interested in applying signal processing to these studies. Late in 2009, he founded OpenVivo ltd a company that distributes medical and biomedical equipment as well as provides consultancy providing custom software solutions for researchers and industry. He's just taken on a role building out the backend services at Felix Stress Management. Dr. Emlyn Clay received his BSc in Pharmacology in 2009 and his PhD in Pharmacology in 2015 from King's College London.